fda tirzepatide obesity FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes

GROUNDBREAKING UPDATE! FDA has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, for weight loss! Previously, Tirzepatide has been FDA approved for type 2 diabetes as Mounjaro, and although

21.54

★★★★☆4.8 (126)

On Nov 8 the FDA approved #tirzepatide for chronic weight management in people with obesity or overweight with weight-related conditions. Here's what to know about #Zepbound, the latest antiobesity drug. https://ja.ma/3NnD3VY #MedicalNews

26.43

★★★★★4.9 (98)

FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity - Eli Lilly

26.89

★★★★★5.0 (157)

Diabetes Drug - Tirzepatide Gets FDA Approval for Weight Loss

20.22

★★★★★4.7 (84)

FDA approves new obesity drug from Eli Lilly named Zepbound

29.08

★★★★★4.9 (203)

Friendly Reminder 💡 The only FDA‑approved U.S. brands of tirzepatide are Mounjaro and Zepbound. All tirzepatide available locally in the Philippines comes from the grey market. Even if tested in U.S. labs

27.03

★★★★★5.0 (176)

Today the FDA issued its fastest approval for a novel drug (NME) since 2002, as part of the national priority voucher pilot program. ✔️ New option for chronic weight management ✔️ Full

27.37

★★★★★4.8 (132)